ctrl K

Watchlist Price Alert

Kestra Medical Technologi... (KMTS)

NASDAQ: KMTS · Real-Time Price · USD

15.10

-1.55 (-9.31%)

At close: Jun 17, 2025, 1:46 PM

Kestra Medical Common Stock Income Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	Q3 2024	Q4 2023	Q3 2023	Q1 2021	Q1 2020
Period Ending	Jan 31, 2025	Apr 30, 2024	Jan 31, 2024	Jul 31, 2021	Jul 31, 2020
Revenue	33.42M	18.33M	8.28M	n/a	n/a
Cost of Revenue	24.6M	16.05M	7.4M	n/a	n/a
Gross Profit	8.82M	2.28M	880K	n/a	n/a
Operating Income	-60.9M	-40.3M	-19.95M	-20.2M	-7.91M
Interest Income	628K	n/a	n/a	n/a	n/a
Pretax Income	-65.66M	-43.92M	-21.61M	-20.98M	-7.91M
Net Income	-65.41M	-43.9M	-21.62M	-21.09M	-7.95M
Selling & General & Admin	58.81M	35.02M	17.09M	9.41M	1.98M
Research & Development	10.91M	7.56M	3.73M	10.78M	5.92M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	69.72M	42.57M	20.83M	20.2M	7.91M
Interest Expense	5.37M	3.59M	1.65M	847K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	9.41M	1.98M
Cost & Expenses	94.32M	58.63M	28.22M	20.2M	7.91M
Income Tax Expense	5K	-13K	14K	104K	47K
Shares Outstanding (Basic)	49.53M	49.53M	49.53M	49.53M	49.53M
Shares Outstanding (Diluted)	49.53M	49.53M	49.53M	49.53M	49.53M
EPS (Basic)	-1.42	-0.92	-0.47	-0.43	-0.16
EPS (Diluted)	-1.42	-0.92	-0.47	-0.43	-0.16
EBITDA	-51.53M	-33.47M	-16.59M	-19.94M	-7.79M
EBIT	-60.29M	-40.33M	-19.95M	-20.14M	-7.91M
Depreciation & Amortization	8.75M	6.87M	3.36M	192K	117K